MediPoint: Women’s Health - Global Analysis and Market Forecasts

Published: November 2015
No. of Pages: 350
   

MediPoint: Women’s Health - Global Analysis and Market Forecasts

Summary

The women’s health medical devices market encompasses treatments for conditions that are particular to the adult female anatomy. This includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, as well as pelvic disorders such as female stress urinary incontinence. Moreover, there is a sub-segment of the female population that no longer desire to become pregnant, and seek permanent solutions to avoid conception.


In recent years, minimally invasive techniques and technologies have been developed to treat these conditions as alternatives to conventional surgery; these technologies are expected to see increased adoption in the coming years due to increased physician and patient awareness as well as an increasing number of women who are proactively seeking treatment for these embarrassing, and sometimes debilitating, conditions. However, recent lawsuits related to safety issues with some of these devices that are receiving widespread media attention, particularly in the urinary incontinence sling market, have caused some women to be skeptical of these newer technologies.


The technologies covered in this report include global endometrial devices, endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. This report focuses on the global women’s health market in the 10 major markets (10MM) (US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different types of women’s health devices.


Highlights


Key Questions Answered


- What is the current and future women’s health market outlook in the developed and emerging markets? What trends are affecting the global market?
- Which are the key, high growth markets that manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with women’s health devices currently on the market? How will emerging technologies fulfill these unmet needs?
- What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for women’s health devices?
- What are the challenges that have hindered widespread adoption of newer technologies?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global women’s health market?

Scope

- Overview of women’s health, including anatomy, epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.
- Annualized total women’s health market revenue by type of device, direct and indirect costs of disease, procedure trends, and market outlooks by country through 2021.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
- Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.
- Analysis of the current and future market competition in the global women’s health market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading gynecologists, urogynecologists, interventional radiologists, and general surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

MediPoint: Women’s Health - Global Analysis and Market Forecasts

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 12
1.2 List of Figures 21
2 Introduction 28
2.1 Catalyst 29
2.2 Related Reports 29
3 Industry Overview 30
3.1 Overview 30
3.1.1 Anatomy 30
3.2 Indications 31
3.2.1 Overview 31
3.2.2 Abnormal Uterine Conditions 31
3.2.3 Female Urinary Incontinence 32
3.3 Clinical Presentation 33
3.3.1 Abnormal Uterine Conditions 33
3.3.2 Female Urinary Incontinence 36
3.4 Market Segmentation 38
3.5 Market Access 40
3.5.1 Purchasing Decisions 40
3.6 Influence of Clinical Trials 40
3.7 Adoption 40
3.8 Regulation 41
3.8.1 US 41
3.8.2 5EU 42
3.8.3 Asia-Pacific 43
3.8.4 South America 46
3.9 Reimbursement 47
3.9.1 US 47
3.9.2 5EU 50
3.9.3 Asia-Pacific 54
3.9.4 South America 56
3.10 Procedure Trends 57
3.10.1 Global Overview 57
3.10.2 By Region 58
3.11 Regulatory Issues/Recalls 74
3.11.1 Hologic Discontinues Manufacturing, Marketing, and Sales of Adiana 74
3.11.2 Recall of Numerous Transvaginal Mesh Products 75
3.12 M&As, Key Partnerships 75
3.12.1 Bayer Health Acquires Conceptus for $1.1 Billion 75
3.12.2 Boston Scientific Acquires IoGyn for $65m 75
3.13 Economic Impact 76
3.13.1 Indirect Costs 76
3.13.2 Direct Costs 76
4 Unmet Needs 78
4.1 Overview 78
4.2 Endometrial Ablation/Resection Devices 78
4.2.1 Better Fluid Management 78
4.2.2 Improved Imaging Guidance 79
4.2.3 Regulating Depth of Ablation 79
4.3 Uterine Fibroid Embolization Agents 80
4.3.1 Addressing Fibroid Recurrence 80
4.3.2 Assessing Effect on Fertility 80
4.3.3 Preventing Ovarian Failure 81
4.4 Female Sterilization Devices 81
4.4.1 Accelerated Scar Tissue Formation 81
4.4.2 Lack of Reversibility 82
4.4.3 Preventing Micro-insert Migration 83
4.4.4 Preventing Perforation 83
4.4.5 Trocar Size Reduction 84
4.5 Female Urinary Incontinence Slings 84
4.5.1 Anatomical Adaptation 84
4.5.2 Single-Incision Slings 85
5 Market Opportunity Analysis 86
5.1 Overview 86
5.2 Endometrial Ablation/Resection Devices 86
5.2.1 Targeted Fibroid Ablation 86
5.3 Uterine Fibroid Embolization Agents 87
5.3.1 Novel Agents 87
5.4 Female Sterilization Devices 88
5.4.1 Raising Patient Awareness 88
5.4.2 Rapid Transcervical Sterilization 88
5.5 Female Urinary Incontinence Slings 89
5.5.1 Materials and Coatings 89
5.5.2 European and APAC Markets 89
6 Market Drivers and Barriers 91
6.1 Endometrial Ablation/Resection 91
6.1.1 Driver: Patient Preference for Minimally Invasive Treatments 91
6.1.2 Driver: Growing Procedure Volume 91
6.1.3 Barrier: High Device and Procedure Cost 92
6.1.4 Substitute: Hysterectomy 92
6.1.5 Substitute: Intrauterine Devices 93
6.2 Uterine Fibroid Embolization Agents 94
6.2.1 Driver: Increasing Prevalence of Uterine Fibroids 94
6.2.2 Driver: Improving Imaging Capabilities 94
6.2.3 Barrier: Lack of Patient Awareness 94
6.2.4 Substitute: MRI-guided Focused Ultrasound 95
6.2.5 Substitute: Myomectomy 95
6.3 Female Sterilization Devices 96
6.3.1 Driver: Growing Female Population using Modern Contraception 96
6.3.2 Driver: Increasing Adoption of Transcervical Sterilization 96
6.3.3 Barrier: Patient Preference for Reversible Contraception 96
6.3.4 Substitute: Traditional Contraception 97
6.4 Female Urinary Incontinence Slings 97
6.4.1 Driver: Growing Treatment Rates and Use of Surgery 97
6.4.2 Barrier: Highly Litigious US Market 98
6.4.3 Substitute: Surgical Repair 98
6.4.4 Substitute: Pelvic Floor Electrical Stimulation 99
7 Competitive Assessment 100
7.1 Overview 100
7.2 Classification Based on Features 101
7.2.1 Endometrial Ablation Devices 101
7.2.2 Endometrial Resection Devices 102
7.2.3 Uterine Fibroid Embolization Agents 103
7.2.4 Female Sterilization Devices 104
7.2.5 Female Urinary Incontinence Slings 105
7.3 Key Product Profiles 106
7.3.1 Endometrial Ablation Devices 106
7.3.2 Endometrial Resection Devices 119
7.3.3 Uterine Fibroid Embolization Agents 126
7.3.4 Female Sterilization Devices 132
7.3.5 Female Urinary Incontinence Slings 134
8 Pipeline Assessment 141
8.1 Overview 141
8.2 Key Product Profiles 141
8.2.1 Endometrial Ablation Devices 141
8.2.2 Uterine Fibroid Embolization Agents 143
8.2.3 Female Sterilization Devices 144
8.2.4 Female Urinary Incontinence Slings 145
9 Clinical Trials to Watch 148
9.1 Overview 148
9.2 Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation 148
9.3 Post Market Study of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 149
9.4 Safety & Effectiveness Study of Aegea Vapor System to Treat Excessive Uterine Bleeding 149
9.5 The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 149
10 Current and Future Players 151
10.1 Overview 151
10.2 Trends in Corporate Strategy 151
10.3 Company Profiles 151
10.3.1 American Medical Systems 151
10.3.2 AngioDynamics 152
10.3.3 Bayer Healthcare (Bayer AG) 154
10.3.4 Boston Scientific 156
10.3.5 BTG 157
10.3.6 Coloplast 159
10.3.7 Cook Medical 160
10.3.8 CooperSurgical 161
10.3.9 C.R. Bard 163
10.3.10 Ethicon (Johnson & Johnson) 164
10.3.11 Femcare-Nikomed (Utah Medical Products) 166
10.3.12 Hologic 167
10.3.13 Karl Storz 168
10.3.14 Olympus 169
10.3.15 Richard Wolf 171
10.3.16 Stryker 172
11 Market Outlook 174
11.1 Company Market Share 174
11.1.1 Global Overview 174
11.1.2 By Segment 174
11.2 By Market Segment 182
11.2.1 Global Overview 182
11.2.2 By Segment 184
11.3 By Geography 199
11.3.1 Global Overview 199
11.3.2 By Region 202
11.3.3 By Country 208
12 Appendix 321
12.1 Bibliography 321
12.2 Abbreviations 337
12.3 Report Methodology 341
12.3.1 Overview 341
12.3.2 Coverage 341
12.3.3 Secondary Research 341
12.4 Forecasting Methodology 343
12.5 Physicians and Specialists Included in This Study 344
12.6 Primary Research - Prescriber Survey 346
12.7 About the Authors 347
12.7.1 Analysts 347
12.7.2 Global Head of Medical Devices 348
12.8 About GlobalData 349
12.9 Disclaimer 349

1.1 List of Tables
Table 1: Types of Uterine Fibroids 32
Table 2: Types of Female Urinary Incontinence 32
Table 3: Drug and Hormone Treatments for Menorrhagia 34
Table 4: Surgical Treatments for Menorrhagia 35
Table 5: Treatments for Stress, Urge, and Mixed Urinary Incontinence 37
Table 6: Market Segmentation for Women’s Health Market 39
Table 7: FDA Medical Device Classification System 41
Table 8: Regulatory Differences Between the US and EU for the Approval of Medical Devices 42
Table 9: CPT Codes and Description of Coverage for Gynecological Procedures 48
Table 10: APC Codes and Description of Coverage for Gynecological Procedures 48
Table 11: ICD-10 Codes Associated with Causes of Menorrhagia and Uterine Fibroids 49
Table 12: CPT Codes and Description of Coverage for Urinary Incontinence Sling Procedures 49
Table 13: APC Codes and Description of Coverage for Urinary Incontinence Sling Procedures 49
Table 14: ICD-10 Codes Associated with Female Stress Urinary Incontinence 50
Table 15: Endometrial Ablation Devices, SWOT Analysis, 2015 101
Table 16: Currently Marketed Endometrial Ablation Devices, 2015 102
Table 17: Endometrial Resection, SWOT Analysis, 2015 102
Table 18: Uterine Fibroid Embolization, SWOT Analysis, 2015 104
Table 19: Device-based Permanent Female Sterilization, SWOT Analysis, 2015 105
Table 20: Currently Marketed Notable Female Urinary Incontinence Slings, 2015 106
Table 21: Female Urinary Incontinence Slings, SWOT Analysis, 2015 106
Table 22: Product Profile - Cavaterm (Veldana Medical) 107
Table 23: Cavaterm, SWOT Analysis, 2015 108
Table 24: Product Profile - ThermaChoice (Ethicon) 109
Table 25: ThermaChoice, SWOT Analysis, 2015 109
Table 26: Product Profile - Genesys HTA (Boston Scientific) 110
Table 27: Genesys HTA, SWOT Analysis, 2015 111
Table 28: Product Profile - NovaSure (Hologic) 112
Table 29: NovaSure, SWOT Analysis, 2015 112
Table 30: Product Profile - Minerva Endometrial Ablation System (Minerva Surgical) 113
Table 31: Minerva Endometrial Ablation System, SWOT Analysis, 2015 114
Table 32: Product Profile - Her Option (CooperSurgical) 114
Table 33: Her Option, SWOT Analysis, 2015 115
Table 34: Product Profile - Acculis MTA (AngioDynamics) 116
Table 35: Acculis MTA, SWOT Analysis, 2015 117
Table 36: Product Profile - Acessa (Halt Medical) 117
Table 37: Acessa, SWOT Analysis, 2015 118
Table 38: Product Profile - Sonata (Gynesonics) 119
Table 39: Sonata, SWOT Analysis, 2015 119
Table 40: Product Profile - 26Fr Continuous Flow Resectoscope (Stryker) 120
Table 41: 26Fr Continuous Flow Resectoscope, SWOT Analysis, 2015 120
Table 42: Product Profile - Karl Storz Bipolar Resectoscope (Karl Storz) 121
Table 43: Karl Storz Bipolar Resectoscope, SWOT Analysis, 2015 122
Table 44: Product Profile - SurgMaster Resectoscope (Olympus) 123
Table 45: SurgMaster Resectoscope, SWOT Analysis, 2015 123
Table 46: Product Profile - Princess Resectoscope (Richard Wolf) 124
Table 47: Princess Resectoscope, SWOT Analysis, 2015 124
Table 48: Product Profile - Versapoint (Ethicon) 125
Table 49: Versapoint, SWOT Analysis, 2015 126
Table 50: Product Profile - Gelfoam (Pfizer) 126
Table 51: Gelfoam, SWOT Analysis, 2015 127
Table 52: Product Profile - Bead Block (BTG) 127
Table 53: Bead Block, SWOT Analysis, 2015 128
Table 54: Product Profile - Contour PVA Embolization Particles (Boston Scientific) 129
Table 55: Contour PVA Embolization Particles, SWOT Analysis, 2015 129
Table 56: Product Profile - PVA Foam Embolization Particles (Cook Medical) 130
Table 57: PVA Foam Embolization Particles, SWOT Analysis, 2015 130
Table 58: Product Profile - Embosphere Microspheres (Merit Medical Systems) 131
Table 59: Embosphere Microspheres, SWOT Analysis, 2015 132
Table 60: Product Profile - Filshie Clip (Femcare-Nikomed) 132
Table 61: Filshie Clip, SWOT Analysis, 2015 133
Table 62: Product Profile - Essure (Bayer Healthcare) 134
Table 63: Essure, SWOT Analysis, 2015 134
Table 64: Product Profile - Align Urethral Support System (C.R. Bard) 135
Table 65: Align Urethral Support System, SWOT Analysis, 2015 135
Table 66: Product Profile - Altis Single Incision Sling (Coloplast) 136
Table 67: Altis Single Incision Sling, SWOT Analysis, 2015 137
Table 68: Product Profile - Gynecare TVT (Ethicon) 137
Table 69: Gynecare TVT, SWOT Analysis, 2015 138
Table 70: Product Profile - MiniArc Single-Incision Sling (American Medical Systems) 139
Table 71: MiniArc Single-Incision Sling, SWOT Analysis, 2015 139
Table 72: Product Profile - Solyx (Boston Scientific) 140
Table 73: Solyx, SWOT Analysis, 2015 140
Table 74: Product Profile - Aegea Vapor System (Aegea Medical) 142
Table 75: Aegea Vapor System, SWOT Analysis, 2015 142
Table 76: Product Profile - Cryothermic Therapy (Channel Medsystems) 143
Table 77: Cryothermic Therapy, SWOT Analysis, 2015 143
Table 78: Product Profile - Biodegradable Bead 144
Table 79: Biodegradable Bead, SWOT Analysis, 2015 144
Table 80: Product Profile - FemBloc 145
Table 81: FemBloc, SWOT Analysis, 2015 145
Table 82: Product Profile - PTMC Mesh 146
Table 83: PTMC Mesh, SWOT Analysis, 2015 146
Table 84: Product Profile - sensiTVT 147
Table 85: sensiTVT, SWOT Analysis, 2015 147
Table 86: Company Profile - American Medical Systems 152
Table 87: American Medical Systems, SWOT Analysis, 2015 152
Table 88: Company Profile - AngioDynamics 153
Table 89: AngioDynamics, SWOT Analysis, 2015 154
Table 90: Company Profile - Bayer Healthcare 155
Table 91: Bayer Healthcare, SWOT Analysis, 2015 155
Table 92: Company Profile - Boston Scientific 156
Table 93: Boston Scientific, SWOT Analysis, 2015 157
Table 94: Company Profile - BTG 158
Table 95: BTG, SWOT Analysis, 2015 158
Table 96: Company Profile - Coloplast 159
Table 97: Coloplast, SWOT Analysis, 2015 160
Table 98: Company Profile - Cook Medical 160
Table 99: Cook Medical, SWOT Analysis, 2015 161
Table 100: Company Profile - CooperSurgical 162
Table 101: CooperSurgical, SWOT Analysis, 2015 162
Table 102: Company Profile - C.R. Bard 163
Table 103: C.R. Bard, SWOT Analysis, 2015 164
Table 104: Company Profile - Ethicon 165
Table 105: Ethicon, SWOT Analysis, 2015 165
Table 106: Company Profile - Femcare-Nikomed 166
Table 107: Femcare-Nikomed, SWOT Analysis, 2015 167
Table 108: Company Profile - Hologic 167
Table 109: Hologic, SWOT Analysis, 2015 168
Table 110: Company Profile - Karl Storz 169
Table 111: Karl Storz, SWOT Analysis, 2015 169
Table 112: Company Profile - Olympus 170
Table 113: Olympus, SWOT Analysis, 2015 170
Table 114: Company Profile - Richard Wolf 171
Table 115: Richard Wolf, SWOT Analysis, 2015 172
Table 116: Company Profile - Stryker 172
Table 117: Stryker, SWOT Analysis, 2015 173
Table 118: Global Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 183
Table 119: Global Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 185
Table 120: Global Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 190
Table 121: Global Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 192
Table 122: Global Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 195
Table 123: Global Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 198
Table 124: Global Women’s Health Market Forecast ($m) by Country, 2011-2021 201
Table 125: 5EU Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 204
Table 126: APAC Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 207
Table 127: US Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 210
Table 128: US Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 212
Table 129: US Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 215
Table 130: US Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 216
Table 131: US Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 218
Table 132: US Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 220
Table 133: France Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 221
Table 134: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 223
Table 135: France Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 226
Table 136: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 227
Table 137: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 229
Table 138: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 231
Table 139: Germany Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 232
Table 140: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 234
Table 141: Germany Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 237
Table 142: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 238
Table 143: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 240
Table 144: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 242
Table 145: Italy Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 244
Table 146: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 246
Table 147: Italy Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 249
Table 148: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 250
Table 149: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 252
Table 150: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 253
Table 151: Spain Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 255
Table 152: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 258
Table 153: Spain Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 260
Table 154: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 261
Table 155: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 263
Table 156: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 265
Table 157: UK Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 266
Table 158: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 268
Table 159: UK Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 271
Table 160: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 272
Table 161: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 275
Table 162: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 276
Table 163: Japan Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 278
Table 164: Japan Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 281
Table 165: Japan Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 282
Table 166: Japan Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 283
Table 167: Japan Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 285
Table 168: Japan Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 287
Table 169: China Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 288
Table 170: China Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 290
Table 171: China Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 293
Table 172: China Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 294
Table 173: China Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 296
Table 174: China Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 298
Table 175: India Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 299
Table 176: India Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 301
Table 177: India Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 304
Table 178: India Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 305
Table 179: India Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 307
Table 180: India Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 309
Table 181: Brazil Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 310
Table 182: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 312
Table 183: Brazil Endometrial Resection Devices Market Forecast ($m) by Market Segment, 2011-2021 315
Table 184: Brazil Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 316
Table 185: Brazil Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 318
Table 186: Brazil Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 320

1.2 List of Figures
Figure 1: Percentage Breakdown of Urinary Incontinence, by Type 33
Figure 2: Percentage of Patients with Menorrhagia Receiving Treatment, by Type 36
Figure 3: Percentage of Patients with Urinary Incontinence Receiving Treatment, by Type 38
Figure 4: US Procedure Volume Forecast, Endometrial Resection, 2011-2021 58
Figure 5: US Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 60
Figure 6: US Procedure Volume Forecast, Female Sterilization, 2011-2021 61
Figure 7: US Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 62
Figure 8: 5EU Procedure Volume Forecast, Endometrial Resection, 2011-2021 63
Figure 9: 5EU Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 64
Figure 10: 5EU Procedure Volume Forecast, Female Sterilization, 2011-2021 65
Figure 11: 5EU Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 66
Figure 12: APAC Procedure Volume Forecast, Endometrial Resection, 2011-2021 67
Figure 13: APAC Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 68
Figure 14: APAC Procedure Volume Forecast, Female Sterilization, 2011-2021 69
Figure 15: APAC Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 70
Figure 16: Brazil Procedure Volume Forecast, Endometrial Resection, 2011-2021 71
Figure 17: Brazil Procedure Volume Forecast, Uterine Artery Embolization, 2011-2021 72
Figure 18: Brazil Procedure Volume Forecast, Female Sterilization, 2011-2021 73
Figure 19: Brazil Procedure Volume Forecast, Urinary Incontinence Slings, 2011-2021 74
Figure 20: Global Company Market Shares for Endometrial Ablation, 2014 175
Figure 21: Global Company Market Shares for Endometrial Resection, 2014 176
Figure 22: Global Company Market Shares for Uterine Fibroid Embolization Agents, 2014 178
Figure 23: Global Company Market Shares for Female Sterilization Devices 2014 179
Figure 24: Global Company Market Shares for Female Urinary Incontinence Slings, 2014 180
Figure 25: 5EU Company Market Shares for Female Urinary Incontinence Slings, 2014 181
Figure 26: APAC Company Market Shares for Female Urinary Incontinence Slings, 2014 182
Figure 27: Global Women’s Health Market Forecast ($m) by Market Segment, 2011-2021 183
Figure 28: Global Women’s Health Market Share by Market Segment, 2014 and 2021 184
Figure 29: Global Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 185
Figure 30: Global Endometrial Ablation Market Share by Market Segment, 2014 and 2021 188
Figure 31: Global Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 189
Figure 32: Global TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 189
Figure 33: Global Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 192
Figure 34: Global Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 194
Figure 35: Global Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 195
Figure 36: Global Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 197
Figure 37: Global Female Urinary Incontinence Slings Market Forecast ($m) by Market Segment, 2011-2021 198
Figure 38: Global Women’s Health Market Forecast ($m) by Country, 2011-2021 200
Figure 39: Global Women’s Health Market Share by Country, 2014 and 2021 202
Figure 40: 5EU Women’s Health Market Forecast ($m) by Segment, 2011-2021 203
Figure 41: 5EU Women’s Health Market Share by Market Segment, 2014 and 2021 205
Figure 42: APAC Women’s Health Market Forecast ($m) by Segment, 2011-2021 206
Figure 43: APAC Women’s Health Market Share by Market Segment, 2014 and 2021 208
Figure 44: US Women’s Health Market Forecast ($m) by Segment, 2011-2021 209
Figure 45: US Women’s Health Market Share by Market Segment, 2014 and 2021 211
Figure 46: US Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 212
Figure 47: US Endometrial Ablation Market Share by Market Segment, 2014 and 2021 213
Figure 48: US Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 214
Figure 49: US TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 214
Figure 50: US Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 216
Figure 51: US Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 217
Figure 52: US Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 218
Figure 53: US Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 219
Figure 54: US Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 220
Figure 55: France Women’s Health Market Forecast ($m) by Segment, 2011-2021 221
Figure 56: France Women’s Health Market Share by Market Segment, 2014 and 2021 222
Figure 57: France Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 223
Figure 58: France Endometrial Ablation Market Share by Market Segment, 2014 and 2021 224
Figure 59: France Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 225
Figure 60: France TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 225
Figure 61: France Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 227
Figure 62: France Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 228
Figure 63: France Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 229
Figure 64: France Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 230
Figure 65: France Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 231
Figure 66: Germany Women’s Health Market Forecast ($m) by Segment, 2011-2021 232
Figure 67: Germany Women’s Health Market Share by Market Segment, 2014 and 2021 233
Figure 68: Germany Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 234
Figure 69: Germany Endometrial Ablation Market Share by Market Segment, 2014 and 2021 235
Figure 70: Germany Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 236
Figure 71: Germany TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 236
Figure 72: Germany Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 238
Figure 73: Germany Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 239
Figure 74: Germany Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 240
Figure 75: Germany Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 241
Figure 76: Germany Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 242
Figure 77: Italy Women’s Health Market Forecast ($m) by Segment, 2011-2021 243
Figure 78: Italy Women’s Health Market Share by Market Segment, 2014 and 2021 245
Figure 79: Italy Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 246
Figure 80: Italy Endometrial Ablation Market Share by Market Segment, 2014 and 2021 247
Figure 81: Italy Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 248
Figure 82: Italy TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 248
Figure 83: Italy Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 250
Figure 84: Italy Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 251
Figure 85: Italy Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 252
Figure 86: Italy Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 253
Figure 87: Spain Women’s Health Market Forecast ($m) by Segment, 2011-2021 254
Figure 88: Spain Women’s Health Market Share by Market Segment, 2014 and 2021 256
Figure 89: Spain Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 257
Figure 90: Spain Endometrial Ablation Market Share by Market Segment, 2014 and 2021 258
Figure 91: Spain Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 259
Figure 92: Spain TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 260
Figure 93: Spain Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 261
Figure 94: Spain Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 262
Figure 95: Spain Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 263
Figure 96: Spain Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 264
Figure 97: Spain Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 265
Figure 98: UK Women’s Health Market Forecast ($m) by Segment, 2011-2021 266
Figure 99: UK Women’s Health Market Share by Market Segment, 2014 and 2021 267
Figure 100: UK Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 268
Figure 101: UK Endometrial Ablation Market Share by Market Segment, 2014 and 2021 269
Figure 102: UK Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 270
Figure 103: UK TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 270
Figure 104: UK Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 272
Figure 105: UK Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 273
Figure 106: UK Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 274
Figure 107: UK Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 275
Figure 108: UK Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 276
Figure 109: Japan Women’s Health Market Forecast ($m) by Segment, 2011-2021 277
Figure 110: Japan Women’s Health Market Share by Market Segment, 2014 and 2021 279
Figure 111: Japan Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 280
Figure 112: Japan Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 281
Figure 113: Japan TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 282
Figure 114: Japan Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 283
Figure 115: Japan Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 284
Figure 116: Japan Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 285
Figure 117: Japan Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 286
Figure 118: Japan Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 287
Figure 119: China Women’s Health Market Forecast ($m) by Segment, 2011-2021 288
Figure 120: China Women’s Health Market Share by Market Segment, 2014 and 2021 289
Figure 121: China Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 290
Figure 122: China Endometrial Ablation Market Share by Market Segment, 2014 and 2021 291
Figure 123: China Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 292
Figure 124: China TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 292
Figure 125: China Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 294
Figure 126: China Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 295
Figure 127: China Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 296
Figure 128: China Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 297
Figure 129: China Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 298
Figure 130: India Women’s Health Market Forecast ($m) by Segment, 2011-2021 299
Figure 131: India Women’s Health Market Share by Market Segment, 2014 and 2021 300
Figure 132: India Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 301
Figure 133: India Endometrial Ablation Market Share by Market Segment, 2014 and 2021 302
Figure 134: India Resectoscopes Market Forecast ($m) by Market Segment, 2011-2021 303
Figure 135: India TCRE Electrodes Market Forecast ($m) by Market Segment, 2011-2021 303
Figure 136: India Uterine Fibroid Embolization Agents Market Forecast ($m) by Market Segment, 2011-2021 305
Figure 137: India Uterine Fibroid Embolization Agents Market Share by Market Segment, 2014 and 2021 306
Figure 138: India Female Sterilization Devices Market Forecast ($m) by Market Segment, 2011-2021 307
Figure 139: India Female Sterilization Devices Market Share by Market Segment, 2014 and 2021 308
Figure 140: India Female Urinary Incontinence Slings Market Forecast ($m), 2011-2021 309
Figure 141: Brazil Women’s Health Market Forecast ($m) by Segment, 2011-2021 310
Figure 142: Brazil Women’s Health Market Share by Market Segment, 2014 and 2021 311
Figure 143: Brazil Endometrial Ablation Market Forecast ($m) by Market Segment, 2011-2021 312
Figure 144: Brazil Endometrial Ablation Market Share by Mar

Published By: GlobalData
Product Code: GlobalData33465


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: